Mark Schoenberg - Mar 18, 2024 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Chief Medical Officer
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Mar 18, 2024
Transactions value $
-$168,600
Form type
4
Date filed
3/20/2024, 04:38 PM
Previous filing
Feb 2, 2024
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Sale -$169K -12K -7.92% $14.05 139K Mar 18, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 A portion of the cash receipts will be used for federal income tax purposes